Zevalin and Ascites - a phase IV clinical study of FDA data

Summary:

Ascites is reported as a side effect among people who take Zevalin (ibritumomab tiuxetan), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Rituxan, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Ascites when taking Zevalin. It is created by eHealthMe based on reports of 2,256 people who have side effects when taking Zevalin from the FDA, and is updated regularly.

What is Zevalin?

Zevalin has active ingredients of ibritumomab tiuxetan. eHealthMe is studying from 2,258 Zevalin users. Check the latest studies of Zevalin.

What is Ascites?

Ascites (accumulation of fluid in the abdominal cavity) is found to be associated with 1,532 drugs and 2,031 conditions by eHealthMe. Check the latest studies of Ascites.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

2,256 people reported to have side effects when taking Zevalin.
Among them, 31 people (1.37%) have Ascites.

Among these 31 people:

How long have people been on Zevalin when they have Ascites? *

What is the gender of people who have Ascites when taking Zevalin? *

female: 10.71 %
male: 89.29 %

What is the age of people who have Ascites when taking Zevalin? *

What are other drugs people take besides Zevalin? *

What are other side effects people have besides Ascites? *

Pleural Effusion (water on the lungs): 18 people, 58.06%
Hepatic Failure (liver failure): 11 people, 35.48%
Thrombocytopenia (decrease of platelets in blood): 10 people, 32.26%
Venoocclusive Liver Disease (small veins in the liver are obstructed): 9 people, 29.03%
Hypotension (abnormally low blood pressure): 7 people, 22.58%
White Blood Cell Count Decreased: 5 people, 16.13%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 5 people, 16.13%
Lung Disorder (lung disease): 5 people, 16.13%
Intestinal Obstruction: 5 people, 16.13%
Acute Kidney Failure: 5 people, 16.13%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 9 people, 29.03%
Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 6 people, 19.35%
Multiple Myeloma (cancer of the plasma cells): 3 people, 9.68%
Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii Stage Iv: 2 people, 6.45%
Non-Hodgkin's Lymphoma Unspecified Histology Indolent (malignant (cancer) cells form in the lymph system- unspecified histology indolent): 1 person, 3.23%
Mantle Cell Lymphoma Stage Iii (cancer of lymphocytes, a type of white blood cell- stage iii): 1 person, 3.23%
Lymphoma (cancer that begins in immune system cells): 1 person, 3.23%
Diffuse Large B-Cell Lymphoma Refractory (cancer of b cells, a type of white blood cell-relapsed): 1 person, 3.23%
Bone Marrow Conditioning Regimen: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Zevalin and have Ascites?

- Check whether Ascites is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zevalin:

Zevalin (2,258 reports)

Ascites treatments and more:

Ascites (42,930 reports)

Browse all side effects of Zevalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ascites:

Ascites (1,532 drugs)

Browse all the conditions that are associated with Ascites:

Ascites (2,031 conditions)

Related publications that referenced our studies

Rajsekhar P, Reddy MM, Vaddera S, Rajini G, Tikeli V, "A Rare Case of Vitamin B12 Deficiency with Ascites", Journal of clinical and diagnostic research: JCDR, 2014 Jan .
Rajsekhar P, Reddy MM, Vaddera S, Rajini G, Tikeli V, "A Rare Case of Vitamin B12 Deficiency with Ascites", Journal of clinical and diagnostic research: JCDR, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ibritumomab tiuxetan (the active ingredients of Zevalin) and Zevalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.